semaglutide oral efficacy and safety of once-daily 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial What to Know About Semaglutide:

This strategy may be enhanced by integrative interventions that target various pathways which can support metabolic health

As a result, your body manages blood sugar more efficiently

The first step is to measure cardiovascular risk more accurately, think in cumulative exposure rather than only 10-year horizons, use apoB where possible and especially where standard markers are most likely to underrepresent risk, intervene earlier when trajectory, family history, metabolic phenotype, or imaging suggest that the risk is being understated, and keep treatment burden proportional to the quality of evidence and the person in front of the doctor

R., Thakkar, S